As seen on:
As seen on:
Latest Articles
There are numerous similarities between Singapore and Malaysia, if you look carefully. As neighbours, we…
A 5% yield sounds attractive, but reliability matters more than headline numbers. These three Singapore REITs combine steady cash flow with sustainable distributions.
The STI hit 5,000 twice this year. We analyse three Singapore blue chips to watch during this pullback.
This week’s Smart Reads looks at buying blue chips at record highs, dividend stocks beating CPF rates, and how to position amid geopolitical risks. We also compare REITs vs banks and data centre REIT leaders.
It is quite refreshing to hear the chair of the Federal Reserve say that he…
We look at the Fed’s latest rate decision, surging energy costs from Middle East strikes, the STI’s 5,000-point recovery, and Suntec REIT’s massive strategic review.
Popular
Keppel DC REIT and Keppel Corporation offer very different risk-return profiles — here’s how to decide which Keppel stock best fits your investment goals.
Transportation stocks may gain as part of a broader recovery taking shape across Asia’s tourism markets.
DBS shares are hitting record highs, but for long-term investors, the real question is whether selling now helps or hurts future returns.
Markets have changed in 2026. Here’s what investment strategies are delivering results today, and which approaches are quietly falling behind.
Stocks
Rising coffee prices in Singapore could signal broader shifts, and these three food businesses may benefit from changing consumer trends and pricing power.
A 5% yield looks the same on a screener whether it’s funded by recurring free cash flow, a long-dated lease book, or a project windfall that is already ending.
When stocks hit multi-year highs, investors face a tough decision. Are these gains a sign of strength, or a signal to take profits?
Gold has performed strongly amid uncertainty, but with stocks offering growth and income, investors may be asking if it’s time to rebalance their portfolios.
Getting Started
The world faces a different kind of problem aside from the pandemic, but one that can be tackled with pharmaceuticals.
With a potential rocky and unsteady recovery post-COVID-19, here’s how you can locate stocks that will do well.
As enticing and appealing as cash might be, the problem is that there is a cost associated with keeping it.
Diversifying your portfolio can help you buffer against crashes and capture opportunities.